二叶式主动脉瓣对生物瓣置换术后远期结局的影响
本研究比较二叶式主动脉瓣(BAV)与三叶式主动脉瓣(TAV)患者行外科主动脉瓣置换术后的远期结局。BAV瓣是晚期死亡的显著保护因素(HR 0.60)。
核心结论
- BAV患者可能不应与TAV患者同等对待来决定主动脉瓣干预方式。
研究设计与样本
- 回顾性研究,纳入2000年1月至2022年6月间1122例因主动脉狭窄行外科主动脉瓣置换术并植入同种牛心包支架生物瓣的患者(TAV 562例,BAV 560例),倾向性评分匹配后形成350对。
主要发现
- 匹配组间围术期结局(包括因出血再手术、房颤、需起搏器的心脏传导阻滞、卒中、需透析、手术死亡)相似。
- 晚期死亡的危险因素包括年龄、慢性肺病、低射血分数和肾衰竭透析。
临床怎么用
- 原文未报告临床实践推荐。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There are limited data comparing the outcomes of aortic valve replacement surgery between patients with bicuspid aortic valve (BAV) vs tricuspid aortic valve (TAV) morphology. METHODS: From January 2000 to June 2022, 1122 patients with TAV (n = 562) or BAV (n = 560) underwent surgical aortic valve replacement for aortic stenosis with the same type of bovine pericardial stented bioprosthesis. Propensity score matching identified 350 pairs by matching for age, sex, operative status, chronic lung disease, prior stroke, diabetes, ejection fraction, renal failure on dialysis, coronary artery disease, prior cardiac surgery, and concomitant procedures. The primary end points were long-term survival and reoperation. RESULTS: Perioperative outcomes, including reoperation for bleeding, atrial fibrillation, heart block requiring pacemaker, stroke, need for dialysis, and operative mortality, were similar between the matched groups. Survival at 10 years was 67% (95% CI, 59%-74%) in the BAV group and 54% (95% CI, 46%-61%) in the TAV group (P = .001). BAV valve was a significant protective factor for late mortality, with a hazard ratio of 0.60 (95% CI, 0.45-0.81; P < .001). Risk factors for late mortality included age, chronic lung disease, low ejection fraction, and renal failure on dialysis. Cumulative incidence of aortic valve reintervention at 10 years was similar between the groups at 10% in the BAV group and 4.9% in the TAV group (P = .55). CONCLUSIONS: Patients with BAV likely could not be considered the same as patients with TAV when deciding on the approach of aortic valve intervention.
引用
- Makkinejad A, Satija D, Monaghan K, et al. The Impact of Bicuspid Aortic Valve on Long-term Outcomes After Bioprosthetic Valve Replacement. Ann Thorac Surg. 2024. PMID: 39033902. doi:10.1016/j.athoracsur.2024.07.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。